ID: ALA3920367

Max Phase: Preclinical

Molecular Formula: C16H16N4O3

Molecular Weight: 312.33

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  O=C(/C=C/c1ccc([N+](=O)[O-])cc1)c1cn(C2CCCC2)nn1

Standard InChI:  InChI=1S/C16H16N4O3/c21-16(10-7-12-5-8-14(9-6-12)20(22)23)15-11-19(18-17-15)13-3-1-2-4-13/h5-11,13H,1-4H2/b10-7+

Standard InChI Key:  QRNSFLCNPQFNES-JXMROGBWSA-N

Associated Targets(non-human)

Protein-glutamine gamma-glutamyltransferase 2 55 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 312.33Molecular Weight (Monoisotopic): 312.1222AlogP: 3.20#Rotatable Bonds: 5
Polar Surface Area: 90.92Molecular Species: NEUTRALHBA: 6HBD: 0
#RO5 Violations: 0HBA (Lipinski): 7HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: CX LogP: 3.62CX LogD: 3.62
Aromatic Rings: 2Heavy Atoms: 23QED Weighted: 0.37Np Likeness Score: -1.33

References

1.  (2015)  Cinnamoyl inhibitors of transglutaminase, 

Source

Source(1):